Vietnamese crab exporter
Advertisement

Bharat Biotech seeks emergency use authorisation for Covid vaccine Covaxin in India

Hyderabad-based Bharat Biotech has sought emergency use auhtorisation from the Drug Controller General of India (DGCI) for its indigenously made Covid vaccine Covaxin.

After Pfizer and the Serum Institute of India, Bharat Biotech has become the third pharmaceutical in India to seek emergency use authorisation for its Covid vaccine in India.

Read More

VIDEOS FROM OTHER SECTIONS

LATEST VIDEOS

'Namo Drone Didis Have Proved Sceptics Wrong': PM Narendra Modi

Addressing an audience of entrepreneurs, MSMEs, and industry leaders, Prime Minister Narendra Modi highlighted the swift transformation of Indian agriculture through cutting-edge technology and engineering. He noted that rural women operating under the Namo Drone Didi initiative have broken traditional stereotypes and gained respect as certified pilots while spraying fertilizers and pesticides. Urging startups and equipment manufacturers to focus on solar-powered farm machinery and sensor-driven AI tools, he underlined the central government's vision of turning cultivators into successful agripreneurs. Recalling the impact of Gujarat's Jyoti Gram Yojana on local chili farmers through rural electrification and value addition, he reiterated that safeguarding farmers remains his administration's foremost priority. Modi revealed that the government spent sixteen lakh crore rupees over the past twelve years on fertilizer subsidies, ensuring urea and DAP remain affordable despite global geopolitical volatility. Furthermore, he noted that the government has been bearing a monthly loss of fourteen thousand crore rupees on fuel to prevent steep global crude oil spikes from burdening Indian citizens and cultivators.

advertisement